Skip to main content
Published Online:https://doi.org/10.3928/23258160-20130909-18Cited by:4

Abstract

Paracentral occlusive retinopathy is an uncommon manifestation of sickle cell disease. If macular ischemia is not reversed, permanent vision loss can result. The authors report the successful use of exchange transfusion to treat unilateral paracentral occlusive retinopathy secondary to sickle cell disease in a 23-year-old man with hemoglobin SS disease. Initial presentation demonstrated arteriolar occlusion, perivenous hemorrhages, vessel tortuosity, and areas of retinal ischemia. Visual acuity was count fingers, and the patient noted a paracentral scotoma. Following transfusion, there was restoration of arteriolar flow as documented with fluorescein angiogram, and visual acuity returned to 20/20.

[Ophthalmic Surg Lasers Imaging Retina. 2013;44:505–507.]

  • 1.Talbot JF, Bird AC, Maude GH. Sickle cell retinopathy in Jamaican children: further observations from a cohort study. Br J Ophthalmol. 1988; 72(10):727–732.10.1136/bjo.72.10.727

    Crossref MedlineGoogle Scholar
  • 2.Fox PD, Vessey SJR, Forshaw ML, Serjeant GR. Influence of genotype on the natural history of untreated proliferative sickle retinopathy – an angiographic study. Br J Ophthalmol. 1991; 75(4):229–23110.1136/bjo.75.4.229

    Crossref MedlineGoogle Scholar
  • 3.Merritt JC, Risco JM, Pantell JP. Bilateral macular infarction in SS disease. J Pediatr Ophthalmol Strabismus. 1982; 19(5):275–278

    LinkGoogle Scholar
  • 4.Chalam KV, Shah VA. Macular infarction a presentation of sickle cell crisis. Eye (Lond). 2004; 18(12):1277–1278.10.1038/sj.eye.6701409

    Crossref MedlineGoogle Scholar
  • 5.Fine LC, Petrovic V, Irvine AR, Bhisitkul RB. Spontaneous central retinal artery occlusion in hemoglobin sickle cell disease. Am J Ophthalmol. 2000; 129(5):680–681.10.1016/S0002-9394(00)00361-5

    Crossref MedlineGoogle Scholar
  • 6.Hedreville M, Connes P, Romana M, et al.Central retinal vein occlusion in a sickle cell trait carrier after a cycling race. Med Sci Sports Exerc. 2009; 41(1):14–18.10.1249/MSS.0b013e31818313d0

    Crossref MedlineGoogle Scholar
  • 7.Al-Abdulla NA, Haddock TA, Kerrison JB, Goldberg MF. Sickle cell disease presenting with extensive perimacular arteriolar occlusions in a nine-year-old boy. Am J Ophthalmol. 2001; 131(2):275–276.10.1016/S0002-9394(00)00778-9

    Crossref MedlineGoogle Scholar
  • 8.Makhoul D, Kolyvras N, Benchekroun S, Willermain F, Caspers L. Sickle cell crisis presenting as a masquerade syndrome complicated by macular ischemia. Ocul Immunol Inflamm. 2010; 18(3):178–180.10.3109/09273940903562232

    Crossref MedlineGoogle Scholar
  • 9.Asdourian GK, Nagpal KC, Busse B, et al.Macular and perimacular vascular remodeling in sickling haemoglobinopathies. Br J Ophthalmol. 1976; 60(6):431–453.10.1136/bjo.60.6.431

    Crossref MedlineGoogle Scholar
  • 10.Sanders RJ, Brown GC, Rosenstein RB, Magargal L. Foveal avascular zone diameter and sickle cell disease. Arch Ophthalmol. 1991; 109(6):812–815.10.1001/archopht.1991.01080060076029

    Crossref MedlineGoogle Scholar
  • 11.Chow CC, Shah RJ, Lim JI, Chau FY, Hallak JA, Vajaranant TS. Peri-papillary retinal nerve fiber layer thickness in sickle cell hemoglobin-opathies using spectral domain optical coherence tomography. Am J Ophthalmol. 2013; 155(3):456–464.10.1016/j.ajo.2012.09.015

    Crossref MedlineGoogle Scholar
  • 12.Khwarg SG, Feldman S, Ligh J, Straatsma BR. Exchange transfusion in sickling maculopathy. Retina. 1985; 5(4):227–229.10.1097/00006982-198500540-00007

    Crossref MedlineGoogle Scholar
  • 13.Leveziel N, Kirsch O, Lautier-Frau M, Driss F, Offret H, Labetoulle M. Recovery of sickle cell disease ischemic maculopathy after erythropheresis: a clinical case study. J Fr Opthalmol. 2005; 28(6):642–645.10.1016/S0181-5512(05)81110-6

    Crossref MedlineGoogle Scholar

We use cookies on this site to enhance your user experience. For a complete overview of all the cookies used, please see our privacy policy.

×